New guidelines may slightly increase reliability, accuracy of melanoma diagnoses

May 21, 2018 by David Olmos, University of California, Los Angeles
Scan (at two resolutions) of a category 3 melanoma in situ. Credit: The BMJ

In a new study, researchers have developed updated guidelines for classifying a serious form of skin cancer called invasive melanoma. The American Joint Committee on Cancer, an organization that provides information on "cancer staging," or the severity of individual cases of cancer, recently updated its guidelines for melanoma. The researchers found that when pathologists used the new guidelines for cases of early stage invasive melanoma, they agreed with an expert-defined diagnosis 10 percent more often.

In the study, researchers reviewed 4,342 analyses of 116 cases of invasive melanoma, made by a total of 187 pathologists from 10 U.S. states.

The physicians' interpretations were compared with an expert consensus to assess accuracy. The pathologists were unaware that they were interpreting the same set of cases twice; the second viewing occurred at least eight months after the first.

Every few years, the AJCC updates guidelines for categorizing cancers. Physicians use the guidelines to estimate patients' prognosis, determine surgical options, and evaluate whether they are candidates for other therapies or clinical trials. The guidelines should enable pathologists to provide an accurate diagnosis that would be the same as the diagnosis another pathologist would give.

In a prior study, the same researchers showed that pathologists disagreed about the diagnosis of early-stage invasive melanoma more than 50 percent of the time, and they wanted to learn if the new guidelines would lead to more reliable diagnoses.

Pathologists may be able to more accurately classify invasive melanoma using the new guidelines. Although there was only slight improvement in how often pathologists agreed on characterizing invasive melanoma, that difference could help improve treatment outcomes for some patients.

Still, the likelihood that will agree on the diagnosis of early-stage tissue and make an accurate diagnosis is low.

The study was published in the JAMA Network Open.

Explore further: Study raises concern over accuracy of melanoma diagnoses

Related Stories

Study raises concern over accuracy of melanoma diagnoses

June 28, 2017
Concerns over the accuracy of melanoma diagnoses are raised in a study of US pathologists published by The BMJ today.

Pathologists vary in suggested therapy for melanocytic lesions

December 20, 2016
(HealthDay)—Pathologists have wide variability in treatment suggestions for melanocytic lesions, according to a study published in the January issue of the Journal of the American Academy of Dermatology.

Pathologists often disagree on breast biopsy results when diagnosing DCIS

March 21, 2016
A study applying B-Path (Breast Pathology) Study results to patient populations found that pathologists disagree with one another about 8 percent of the time when diagnosing a single breast biopsy slide. Discordance was more ...

Review of appendix cancer cases finds over diagnosis

June 8, 2017
Lesions of the appendix are being over diagnosed as invasive cancer, report University of California San Diego School of Medicine researchers in a paper published June 7 in the journal PLOS ONE.

Skin cancers linked with reduced risk of Alzheimer's disease

April 19, 2018
Previous studies have demonstrated a decreased risk of Alzheimer's disease (AD) in individuals with various cancers, including non-melanoma skin cancers (including squamous cell cancers and basal cell cancers). A new Journal ...

Updated guideline for molecular testing and targeted therapies in lung cancer

January 23, 2018
A panel of leading experts in molecular pathology has issued new recommendations and updates to guidelines for molecular diagnostic testing of patients with lung cancer. The new guidelines reflect recent advancements, as ...

Recommended for you

Existing treatment could be used for common 'untreatable' form of lung cancer

June 21, 2018
A cancer treatment already approved for use in certain types of cancer has been found to block cell growth in a common form of lung cancer for which there is currently no specific treatment available.

Researchers uncover new target to stop cancer growth

June 21, 2018
Researchers at the University of Wisconsin-Madison have discovered that a protein called Munc13-4 helps cancer cells secrete large numbers of exosomes—tiny, membrane-bound packages containing proteins and RNAs that stimulate ...

Novel therapy makes oxidative stress deadly to cancer

June 21, 2018
Oxidative stress can help tumors thrive, but one way novel cancer treatments work is by pushing levels to the point where it instead helps them die, scientists report.

New therapeutic opportunity for the treatment of resistant malignant melanoma

June 21, 2018
A team of researchers led by Dr. Pierre Close, WELBIO researcher at the ULiège GIGA Institute and Dr. Francesca Rapino has uncovered a new therapeutic opportunity in the treatment of malignant melanoma that has acquired ...

New treatment helps avoid deafness in child chemotherapy patients

June 21, 2018
An international trial has found that a medicine commonly used to treat poisoning is effective in reducing deafness in children receiving chemotherapy for cancer.

Biologists discover how pancreatic tumors lead to weight loss

June 20, 2018
Patients with pancreatic cancer usually experience significant weight loss, which can begin very early in the disease. A new study from MIT and Dana-Farber Cancer Institute offers insight into how this happens, and suggests ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.